SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2015 / Cilt: 57 - Sayı: 5

Clinical features and treatment results in children with anaplastic large cell lymphoma

Erman Ataş
M. Tezer KUTLUK
Canan AKYÜZ
Gülsev KALE
Ali VARAN
Bilgehan YALÇIN
Burça AYDIN
Münevver BÜYÜKPAMUKÇU
Pages
458–466
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Event-free survival (EFS) and overall survival (OS) rates for 23 children were 32.2% and 72.8% at 3 years, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anaplastic large cell lymphoma (ALCL) tends to have frequent relapse and good response to salvage chemotherapy.
📊
Key Findings & Data:The frequency of ALCL among 1486 Non-Hodgkin's lymphoma (NHL) cases followed-up since 1972 was 1.5%, however, the percentage was 9.3% in cases diagnosed after 2000.
💡
Conclusion & Impact:Event-free survival (EFS) and overall survival (OS) rates for 23 children were 32.2% and 72.8% at 3 years, respectively.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

Anaplastic large cell lymphoma (ALCL) tends to have frequent relapse and good response to salvage chemotherapy. The frequency of ALCL among 1486 Non-Hodgkin's lymphoma (NHL) cases followed-up since 1972 was 1.5%, however, the percentage was 9.3% in cases diagnosed after 2000. Event-free survival (EFS) and overall survival (OS) rates for 23 children were 32.2% and 72.8% at 3 years, respectively. Disseminated diseases, no response to first line treatment, anaplastic lymphoma kinase (ALK) negativity were found as significant predictors on survival of ALCL. The proper diagnosis and early referral is essential in these children for a better survival rate. The children with ALK negative status should be monitored carefully because of the poor prognostic factors, and treated differently. The survival rates in this study are need of further improvement since the survival rates with current protocols are achievable at a level more than 80%. This is mainly related with late referral of those children with advanced disease.

🔖

Cite This Article

Ataş, E., KUTLUK, M. T., AKYÜZ, C., KALE, G., VARAN, A., YALÇIN, B., AYDIN, B., BÜYÜKPAMUKÇU, M. (2015). Clinical features and treatment results in children with anaplastic large cell lymphoma. Turkish Journal of Pediatrics, Cilt: 57 - Sayı: 5, 458–466. https://ajindex.com/articles/412293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kutluk MT, Yeşilipek A. Turkish National Pediatric Cancer Registry 2002-2008 (Turkish Pediatric Oncology Group and Turkish Pediatric Hematology Society). J Clin Oncol 2013; 31
  2. Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 2005; 131: 39-49
  3. Jaffe E, Harris NL, Stein H, et al. Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow S, Campo E, Harris NL, et al.(ed). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th ed) Lyon, France: International Agency for Research on Cancer; 2008: 157-166
  4. Mora J, Filippa DA, Thaler HT, Polyak T, Cranor ML, Wollner N. Large cell non-Hodgkin lymphoma of childhood: analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial SloanKettering Cancer Center. Cancer 2000; 88: 186-197
  5. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010; 28: 2625-2634
  6. Williams DM, Hobson R, Imeson J, et al. Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 2002; 117: 812-820
  7. Lamant L, McCarthy K, d'Amore E, et al. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol 2011; 29: 4669-4676
  8. Seidemann K, Tiemann M, Schrappe M, et al. Shortpulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 2001; 97: 3699-3706
  9. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980; 7: 332-339
  10. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc of Hematol Educ Program 2009: 523-531
  11. Bergeron C, Patte C, Leverger G, et al. Treatment of childhood lymphoblastic lymphomas. Results of the SFOP LMT 89 protocol. International Society of Pediatric Oncology SIOP XXIX Meeting, Istanbul, Turkey, September 23-27, 1997. Med Pediatr Oncol 1997; 29: 313-500
  12. A predictive model for ag